At the beginning of the COVID-19 crisis, the vast majority of states across the country implemented "stay at home" orders requiring the closure of, or severely restricting,.
As the COVID-19 public health emergency drags into its third year, we continue to keep track of efforts by the Food and Drug Administration (FDA) to combat fraud in the form of fake cures.
The USPTO has issued proposed rules to make permanent a Covid-19-related change in the manner in which applications for patent term extension under 35 USC § 156 are to be filed.
The deadline to request a COVID-19 Economic Injury Disaster Loan (EIDL) loan increase or reconsideration is this Friday, May 6, 2022. The COVID-19 EIDL portal (also known as the "RAPID portal") will close on May 16, 2022.